Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$127.00
Provider: S&P Capital IQ Quantitative Report
$58.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$250.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Given Imaging Ltd Halts Sale Review, Investor May Sell Stake-Reuters


Tuesday, 15 Jan 2013 03:10am EST 

Reuters reported that Given Imaging is no longer considering a sale or merger and will instead focus on its existing operating plan, as well as potential acquisitions and alliances, the camera-in-a-pill maker said. The Israeli medical devices maker also said 45.5% shareholder Discount Investment Corp planned to seek and consider a sale of its stake in one block. There can be no assurance that any transaction will occur, Given Imaging added. Terms of the transaction were not disclosed. 

Company Quote

14.92
-0.31 -2.04%
10:47am EDT